Microfluidic Lymph Node Chip Layout for Human Immune Response Modeling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine development is hindered by the lack of comprehensive preclinical data and interspecies differences between animal models and humans, leading to inaccurate immune response replication and ethical concerns in clinical trials, necessitating the need for humanized models that simulate adaptive immune responses in lymph nodes.
Innovation Solution
A lymph node on a chip device is developed, comprising a microfluidic chip with partitioned regions and micropillars to mimic human lymph node compartments, incorporating various cell types and extracellular matrix components, allowing for the simulation of adaptive immune responses and evaluation of vaccine efficacy across different populations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal models are used to study immune responses, then ethical concerns are reduced and large-scale testing is enabled, but interspecies differences lead to inaccurate replication of human immune responses
Solution Approach 1:
The patent creates a humanized lymph node model by copying and transplanting human cells (T cells, B cells, dendritic cells, stromal cells) into a mouse lymph node, thereby replicating human immune responses in a manageable animal system. This allows accurate study of human-specific immune mechanisms while maintaining the ethical and practical benefits of animal modeling.
Solution Approach 2:
The patent embeds human cellular components within the mouse lymph node structure, creating a nested system where human immune cells are housed within the mouse organ. This nested architecture enables the mouse lymph node to function as a humanized model, allowing researchers to study human immune responses while using the mouse system for containment and experimentation.
2Reliability
If human lymph nodes are studied directly, then accurate human immune responses are observed, but ethical concerns and logistical complexity increase
Solution Approach 1:
The patent uses a mouse lymph node as an intermediary system that has been humanized through cell transplantation. This intermediary model allows researchers to study human immune responses without directly working with human tissues, thereby reducing ethical complexity and logistical barriers while maintaining biological relevance to human immunity.
Solution Approach 2:
The patent copies human immune cells and their functional characteristics into the mouse lymph node, creating a functional replica of human immune architecture. This copying approach enables the study of human-specific immune mechanisms in a controlled animal system, avoiding the need for direct human tissue analysis while preserving scientific accuracy.
3Measurement precision
If comprehensive preclinical data is collected from human samples, then accurate vaccine efficacy assessment is achieved, but time and resource requirements increase
Solution Approach 1:
The patent establishes a humanized lymph node model that can be used for preliminary vaccine testing before human clinical trials. By pre-characterizing the model's immune response properties and establishing baseline data in the humanized mouse system, researchers can efficiently screen and select vaccine candidates that show promise in this controlled model, thereby reducing the time and resources needed for subsequent human trial preparation and execution.
Data Source
AI summary
A lymph node on a chip device includes a microfluidic chip having a top and bottom surface, a central chamber embedded in the chip, one or more openings in the chip fluidly connected to the central chamber with one or more channels, a plurality of micropillars arranged within the central chamber such that the central chamber is partitioned into an inner region, one or more outer regions positioned around the inner region, and a circumferential region surrounding the one or more outer regions, with the micropillars forming channels extending from the inner region to at least the outer region, and paracortex cells configured to mimic a paracortex region positioned in the inner region, follicle cells configured to mimic one or more follicle regions positioned in the one or more outer regions, and interfollicular cells configured to mimic one or more interfollicular regions positioned in the one or more channels.